Full Press Release Details
VSee Health Announces $935K Contracts with Major
Medical Device Manufacturers
SAN JOSE, Calif.-- January 21, 2025 --VSee Health,
Inc. (Nasdaq: VSEE), a leader in comprehensive digital health services and customized telehealth workflow streams, announces contracts
with several medical technology solution companies totaling approximately $935,000. These initial contracts underscore potential growth
opportunities for VSee in this untapped vertical.
"Our partnerships with these medtech leaders
highlight VSee's ability to solve critical challenges in the medical technology industry," stated Dr. Milton Chen, Co-CEO
of VSee Health. "Our platform empowers healthcare equipment and device companies to deliver exceptional services including remote
support and remote operation of their products, resulting in increased client ROI and significant cost reductions."
VSee is recognized for its deep technology and
extensive capabilities. It is distinct in its ability to power remote medical device workflows. Using its lego-like digital health building
blocks, VSee uniquely addresses the needs of medical device manufacturers - from Uber-like routing to the next available support
agent to high fidelity screen sharing and the remote control of the medical devices.
Enabling Remote Support and Remote Biomedical
Medtech purchases are large investments for healthcare
organizations. The VSee platform offers specific features that enable medical device companies to provide key value-adds to their customers:
VSee's Growing Role in Medtech and Digital
The medtech industry is experiencing exponential
growth, with the global market projected to reach $800 billion by 2030 according to Fortune Business Insights. VSee Health's growth
trajectory is aligned to take advantage of this as healthcare providers increasingly incorporate advanced imaging systems, robotics, and
AI-enabled solutions. VSee's customizable, scalable platform is uniquely positioned to enable medical technology companies to enhance
their customer experience, reduce turnaround times, and drive greater adoption of their products.
VSee Health's AI telehealth platform is
the fastest way for enterprises to go from ideation to market go-live. Field-hardened on over 1.5M HIPAA-compliant video encounters every
month, its customizable building blocks meet stringent government security standards, and are ready to scale. VSee Health has traveled
for field deployments to over 50 countries such as Iraq, Syria, Marshall Islands and El Salvador. Its clients include NASA Space Station,
US Department of Health and Human Services, McKesson, Magellan, DaVita, GE, countless startups, and the entire country of Qatar.
VSee Health offerings also include turnkey solutions
for critical shortage areas such as critical care and teleradiology. It is committed to empowering high quality healthcare access and
reducing physician burnout and workforce shortages through its telehealth technology. Visit vseehealth.com.
Forward-Looking Statements
This press release includes "forward-looking
statements" within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995.
Certain of these forward-looking statements can be identified by the use of words such as "believes," "expects, "intends,"
"plans," "estimates," "assumes," "may," "should," "will," "seeks,"
or other similar expressions. Such statements may include, but are not limited to, statements regarding the Company's ability to
regain compliance with Nasdaq's listing rules within the required timeframe. These statements are based on current expectations
on the date of this press release and involve a number of risks and uncertainties that may cause actual results to differ significantly,
including those risks set forth in the Company's most recent Annual Report on Form 10-K and any subsequent Quarterly Reports on
Form 10-Q and other documents filed with the SEC. Copies of such filings are available on the SEC's website at www.sec.gov . The
Company does not assume any obligation to update or revise any such forward- looking statements, whether as the result of new developments
or otherwise. Readers are cautioned not to put undue reliance on forward-looking statements.